This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Wakunaga Pharmaceutical Co., Ltd., Wakunaga Seiyaku Kabushiki Kaisha. Active years: 1989-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hiroshima, JP (1989 - 2019)
- Akitakata, JP (2023)
Company Filing History:
2 out of 30 
1 out of 45 
Years Active: 1989-2023
Title: Mitsuyasu Ushijima: Innovator in Blood Flow and Hypertension Solutions
Introduction
Mitsuyasu Ushijima is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the fields of medicine and pharmacology, particularly in developing solutions for blood flow improvement and hypertension management. With a total of 3 patents, Ushijima's work reflects his commitment to enhancing health and well-being.
Latest Patents
Ushijima's latest patents include a blood flow improver and an antihypertensive agent. The blood flow improver is designed to be safe and effective, utilizing S-1-propenylcysteine or a salt thereof as its active ingredient. Similarly, his antihypertensive agent also features S-1-propenylcysteine, ensuring a mild effect while maintaining safety for users.
Career Highlights
Throughout his career, Ushijima has worked with prominent companies such as Wakunaga Pharmaceutical Co., Ltd. and Wakunaga Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical products.
Collaborations
Ushijima has collaborated with talented individuals in his field, including Yukihiro Kodera and Naoaki Morihara. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
Mitsuyasu Ushijima's contributions to medical innovation, particularly in blood flow and hypertension solutions, highlight his dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing pharmaceutical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile